204 related articles for article (PubMed ID: 9620709)
1. Are angiostatin and endostatin cures for cancer?
Harris AL
Lancet; 1998 May; 351(9116):1598-9. PubMed ID: 9620709
[No Abstract] [Full Text] [Related]
2. [Angiostatin. A biological inhibitor of tumor angiogenesis].
Thimme R; Spangenberg HC; Blum HE
Dtsch Med Wochenschr; 1997 Mar; 122(13):413-4. PubMed ID: 9138915
[No Abstract] [Full Text] [Related]
3. [Antiangiogenic therapy].
Toi M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
[TBL] [Abstract][Full Text] [Related]
4. Cancer 'cure' article stirs up hot debate.
Wadman M
Nature; 1998 May; 393(6681):104-5. PubMed ID: 9603508
[No Abstract] [Full Text] [Related]
5. Angiostatin and endostatin: endogenous inhibitors of tumor growth.
Sim BK; MacDonald NJ; Gubish ER
Cancer Metastasis Rev; 2000; 19(1-2):181-90. PubMed ID: 11191058
[TBL] [Abstract][Full Text] [Related]
6. A new approach to fighting cancer?
Sato TN
Proc Natl Acad Sci U S A; 1998 May; 95(11):5843-4. PubMed ID: 9600880
[No Abstract] [Full Text] [Related]
7. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents.
Phillips P
JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843
[No Abstract] [Full Text] [Related]
8. Anticancer drug targets: approaching angiogenesis.
Keshet E; Ben-Sasson SA
J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
[No Abstract] [Full Text] [Related]
9. [Tumor angiogenesis inhibitors: media and scientific aspects].
Raymond E
Presse Med; 1998 Jul 4-11; 27(24):1221-4. PubMed ID: 9767782
[TBL] [Abstract][Full Text] [Related]
10. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
[TBL] [Abstract][Full Text] [Related]
11. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis: the unifying concept in cancer?
Saphir A
J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
[No Abstract] [Full Text] [Related]
13. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.
Hayes AJ; Li LY; Lippman ME
BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266
[No Abstract] [Full Text] [Related]
14. [Neovascularization and tumor development].
Ono M; Kuwano M
Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1577-87. PubMed ID: 9780690
[No Abstract] [Full Text] [Related]
15. Adeno-associated virus and other potential vectors for angiostatin and endostatin gene therapy.
Nguyen JT
Adv Exp Med Biol; 2000; 465():457-66. PubMed ID: 10810649
[No Abstract] [Full Text] [Related]
16. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
17. [Endostatin and angiostatin: two weapons, a single target].
Lopez M
Clin Ter; 1998; 149(2):95-8. PubMed ID: 9780471
[No Abstract] [Full Text] [Related]
18. Cancer "breakthrough" is still in the future.
Health News; 1998 Jun; 4(7):6. PubMed ID: 9624918
[No Abstract] [Full Text] [Related]
19. A cancer therapy resistant to resistance.
Kerbel RS
Nature; 1997 Nov; 390(6658):335-6. PubMed ID: 9389468
[No Abstract] [Full Text] [Related]
20. The promise of anti-angiogenic cancer therapy.
Oehler MK; Bicknell R
Br J Cancer; 2000 Feb; 82(4):749-52. PubMed ID: 10732738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
